The cheapest GLP-1 in 2026 isn't Ozempic.
It's compounded semaglutide from a telehealth pharmacy, starting at $99 a month. Brand-name injections still cost $1,000 to $1,500 a month without insurance. Compounded options, oral pills, manufacturer cash programs, and the new LillyDirect vial pricing have closed almost the entire affordability gap, if you know where to look.
Quick Answer
The cheapest GLP-1 in 2026 is compounded semaglutide from a 503A telehealth pharmacy at $99 to $249 per month. The cheapest FDA-approved option is the Zepbound 2.5 mg vial via LillyDirect at $299 per month, while oral Wegovy tablets run $149 to $199. With commercial insurance plus a qualifying diagnosis, a Mounjaro or Zepbound savings card drops the cost to $25 per month.
Telehealth Comparison Table
If you'd rather skip the research-vial route, here are the two telehealth providers our readers use most for compounded semaglutide and tirzepatide.
Real GLP-1 before and after results
Four real before-and-after photos from users online who shared their GLP-1 results. Identifiers blurred for privacy. Click any photo to expand.
Photos sourced from users online who publicly shared their GLP-1 results. All four used compounded semaglutide or tirzepatide, the same medications available through MEDVi and Yucca Health telehealth. Individual results vary; trial average is 15-20% body weight loss at 60+ weeks.
🔑 Key Takeaways
- Compounded semaglutide from a 503A pharmacy via telehealth is the cheapest legal route at $99 to $249 per month.
- LillyDirect Self Pay sells Zepbound vials at $299, $399, and $449 depending on dose, the cheapest FDA-approved cash price in the country.
- Oral Wegovy tablets sit between $149 and $199 a month and are the cheapest FDA-approved oral GLP-1.
- Manufacturer savings cards drop Mounjaro and Zepbound to $25 a month if you have commercial insurance and a qualifying diagnosis.
- Hidden fees like membership dues, lab work, shipping, and dose-tier price jumps can add $50 to $200 a month to a low headline price.
Cheapest GLP-1 Options in 2026, Ranked
The pricing landscape changed twice in the last 18 months. First, the FDA ended the semaglutide and tirzepatide shortages, narrowing the legal window for compounding. Then Eli Lilly launched single-dose vials through LillyDirect at vial prices nobody expected to see. Here's where the floor actually sits today.
| Option | Drug | Monthly cost | FDA-approved | Best for |
|---|---|---|---|---|
| Compounded semaglutide (telehealth) | Semaglutide | $99 to $249 | No (503A custom) | Lowest cash price |
| Compounded tirzepatide (telehealth) | Tirzepatide | $125 to $399 | No (503A custom) | Strongest results, low cost |
| Oral Wegovy tablets | Semaglutide | $149 to $199 | Yes | Needle-averse, FDA-approved |
| Zepbound vials (LillyDirect) | Tirzepatide | $299 to $449 | Yes | FDA-approved cash floor |
| Wegovy NovoCare cash program | Semaglutide | $199 first 2 months, then $349 | Yes | Brand semaglutide cash |
| Mounjaro savings card | Tirzepatide | $25 | Yes | Commercial insurance + T2D |
| Zepbound savings card | Tirzepatide | $25 | Yes | Commercial insurance + obesity |
| Brand Ozempic / Mounjaro retail | Various | $1,000 to $1,500 | Yes | Last resort if all else fails |
12-Month Total Cost of Each Cheapest GLP-1 Route
A low monthly headline can still cost you thousands over a year once you titrate up and add platform fees. Here is the realistic 12-month total for each route, assuming you reach a typical maintenance dose by month four.
| Route | Typical monthly (maintenance) | 12-month total | FDA-approved |
|---|---|---|---|
| Compounded semaglutide (telehealth) | $99 to $249 | $1,188 to $2,988 | No (503A custom) |
| Compounded tirzepatide (telehealth) | $125 to $399 | $1,500 to $4,788 | No (503A custom) |
| Oral Wegovy tablets | $149 to $299 | $1,788 to $3,588 | Yes |
| Zepbound vials (LillyDirect) | $299 to $449 | $3,588 to $5,388 | Yes |
| Wegovy NovoCare cash program | $199 first 2 mo, then $349 | $4,090 | Yes |
| Mounjaro or Zepbound savings card | $25 (insured + diagnosis) | $300 (capped by annual savings limit) | Yes |
| Brand Ozempic or Mounjaro retail | $1,000 to $1,500 | $12,000 to $18,000 | Yes |
The annual spread is the real story: the cheapest legal route costs roughly $1,188 a year, while brand-name retail without any savings program can exceed $18,000. That is the 14x gap referenced at the top of this guide. Savings cards cap out fast (Mounjaro caps at $1,950 per year), so a $25 copay is only $25 until the cap is hit, after which the price reverts to your plan's standard cost share.
1. Compounded Semaglutide: $99 to $249 per Month
Compounded semaglutide is what almost every "cheapest GLP-1" article points to first, and the floor keeps falling. A handful of telehealth platforms now anchor under $200, with promotional pricing dipping below $100.
The cheapest verified providers for compounded semaglutide right now:
Lowest-cost compounded semaglutide providers (May 2026)
- Trimi: $99 per month, all-in
- MEDVi: $99 first month, $179 to $279 ongoing
- Eden Health: $129 first month, then $189 to $249
- MyStart Health (Mochi): $149 to $254 per month
- Hims/Hers: $199 to $299 per month
- Henry Meds: $234 per month if prepaid annually
Compounded does not mean fake or generic. A 503A compounding pharmacy mixes the active ingredient (semaglutide base or salt) into a finished injectable, often with a small dose of B12 or another additive that lets the formulation qualify as "personalized" under post-shortage FDA rules. The active drug is the same molecule that goes into Ozempic and Wegovy.
The honest tradeoff: compounded semaglutide is not FDA-approved as a finished product. The compounding pharmacy is regulated, the molecule is the same, but the final preparation has not gone through FDA review. For most people that is an acceptable cost-benefit. For pregnant women, people with thyroid cancer history, or anyone with severe pancreatitis risk, it is not.
2. Oral Wegovy Tablets: $149 to $199 per Month
The cheapest FDA-approved GLP-1 you can buy today is the oral Wegovy tablet, not any injection. Most cost guides skip it because the original Rybelsus version was priced at $900 a month. The 2025 reformulation under the Wegovy brand changed that.
Self-pay platforms now move oral semaglutide for $149 to $199 a month for the lower doses, climbing to $249 to $299 at higher doses. It works less aggressively than the injectable form (the bioavailability is lower), but for people who genuinely cannot or will not inject, it is the cheapest legitimate path to a real GLP-1.
3. LillyDirect Zepbound Vials: $299, $399, $449
This is the price point that broke the brand-name cash market. In 2024 Eli Lilly started selling single-dose Zepbound vials directly to consumers through LillyDirect, bypassing the pen-injector cost entirely.
| Zepbound vial dose | LillyDirect cash price | Annual cost at this dose |
|---|---|---|
| 2.5 mg | $299 per month | $3,588 |
| 5 mg | $399 per month | $4,788 |
| 7.5 mg, 10 mg, 12.5 mg, 15 mg | $449 per month | $5,388 |
You draw the dose from the vial yourself with a separate syringe. That is the only friction. The drug is identical to what comes out of the auto-injector pen. For anyone who wants FDA-approved tirzepatide and is willing to handle a syringe, this is the cheapest legal path, and it beats every compounded option on regulatory standing.
4. Manufacturer Savings Cards: $25 per Month
If you have commercial insurance (employer plan or marketplace, not Medicare or Medicaid), you can stack a savings card on top of your prescription benefit and pay $25 a month for Mounjaro, Zepbound, or Wegovy.
The catch is the diagnosis requirement. Mounjaro's $25 card requires Type 2 diabetes. Zepbound's $25 card requires an obesity diagnosis (BMI 30+, or 27+ with a comorbidity). Wegovy's NovoCare savings card has similar criteria. If your insurance plan has a GLP-1 exclusion for weight-loss indications, the savings card alone won't bridge the gap.
How to actually get the $25 price
- Confirm your insurance covers GLP-1s for your indication (call the pharmacy benefit number on your card).
- Apply for the savings card directly on the manufacturer site (Mounjaro.com, Zepbound.com, NovoCare.com).
- Bring the card to the pharmacy at fill time. The discount is applied at the register, not by your doctor.
- Annual savings caps apply: Mounjaro caps at $1,950 per year; Zepbound and Wegovy have similar limits.
5. NovoCare Pharmacy: Wegovy at $349 per Month
For people who want brand semaglutide (not compounded) but can't get insurance to cover it, Novo Nordisk's NovoCare cash-pay program runs Wegovy at $349 per month. There is an introductory $199 price for the first two months that converts to $349 ongoing.
This is the cheapest brand-name semaglutide injection available without insurance. It is not as cheap as compounded, but it carries the FDA-approved label and the full Novo Nordisk supply chain.
6. Compounded Tirzepatide: $125 to $399 per Month
Compounded tirzepatide costs slightly more than compounded semaglutide because the active ingredient is harder to source and the molecule is more potent per dose. It also delivers stronger results in the published trials, so the per-pound cost can actually be lower.
Lowest-cost compounded tirzepatide providers (May 2026)
- Trimi: $125 per month
- GobyMeds: $119 to $179 per month
- ReflexMD: starting $92 per month (limited dose)
- Henry Meds: $299 to $349 per month
- Eden Health: $299 first month, then $349 ongoing
- Peak Wellness: $229 first month, $349 ongoing, or $1,396 for 6 months ($232 per month)
For a deeper breakdown of where to source tirzepatide specifically, see our cheapest tirzepatide guide.
The Cheapest GLP-1 Drug Class by Class
Not every GLP-1 follows the same pricing curve. Here's how the floor breaks down by molecule:
| Drug | Brand cash retail | Cheapest legal path | FDA-approved low option |
|---|---|---|---|
| Semaglutide (Ozempic, Wegovy) | $1,000 to $1,500 | Compounded $99 to $249 | Oral Wegovy $149 to $199 / NovoCare $349 |
| Tirzepatide (Mounjaro, Zepbound) | $1,000 to $1,400 | Compounded $125 to $399 | LillyDirect vials $299 to $449 |
| Liraglutide (Saxenda, Victoza) | $1,300 to $1,500 | Compounded $99 first / $149 ongoing (Henry Meds) | Authorized generic liraglutide ~$469 |
| Dulaglutide (Trulicity) | $950 to $1,000 | Manufacturer savings card $25 if insured | None below $900 cash |
| Exenatide (Byetta, Bydureon) | $700 to $900 | GoodRx coupons can drop to $400 to $600 | Same |
| Oral semaglutide (Rybelsus) | $900 to $950 | Manufacturer savings card $25 if insured | Oral Wegovy $149 to $199 |
What's Coming in Mid-2026: TrumpRx and Medicare Bridge
Two pricing changes are in motion this year that could move the floor again:
TrumpRx.gov is the new federal portal launching mid-2026 to consolidate manufacturer cash-pay programs into one access point. Initial reporting suggests Zepbound and Wegovy will be available at roughly $350 a month through the portal, slightly above LillyDirect's vial pricing but with the pen-injector form factor.
The Medicare GLP-1 Bridge Program begins July 2026 and is expected to bring qualifying Medicare Part D beneficiaries to a $50 monthly copay for tirzepatide and semaglutide for diabetes indications. Coverage for obesity-only indications remains excluded from Medicare law and is not part of the bridge.
Hidden Costs That Make a Cheap Headline Price Expensive
Most "cheapest GLP-1" articles list the headline monthly price and stop there. The real cost-per-month of a "$99" telehealth plan is often $150 to $250 once everything is added in. Watch for:
Real costs to add to any quoted price
- Membership fees: $20 to $50 per month on top of medication (Mochi, Hims, Ro Body, Noom Med)
- Lab work: $50 to $200 every 3 to 6 months (some platforms include, most don't)
- Shipping: $15 to $30 per refill if not free
- Dose-tier price jumps: Most platforms raise the price 20% to 50% when you titrate to 7.5 mg or higher
- Auto-renewal lock-ins: Many sub-$200 prices require 6 or 12 month prepayment
- Provider visit fees: Initial consultation $19 to $129; some require quarterly check-ins
HSA, FSA, and Discount Cards
If you have an HSA or FSA, both compounded and brand GLP-1s for an obesity diagnosis qualify as eligible expenses. That alone is a 22% to 37% effective discount depending on your tax bracket.
GoodRx and SingleCare discount cards work on Saxenda, Victoza, Byetta, Bydureon, and sometimes Mounjaro/Ozempic at independent pharmacies. The savings on Saxenda and Victoza can be meaningful (15% to 30%). On Ozempic and Mounjaro, GoodRx coupons usually only beat the brand price slightly because the savings card programs are already aggressive.
Compounded vs Brand: How to Decide
The decision tree is shorter than most articles make it sound:
When compounded is the right choice
- You need to start within a week and don't have insurance coverage.
- You've been paying $1,000+ a month and want to cut the bill by 70% or more.
- You don't qualify for a manufacturer savings card (no commercial insurance, or no qualifying diagnosis).
- You've already done the labs and have no contraindications.
When brand-name is worth the higher price
- You qualify for a $25 savings card (insured + qualifying diagnosis).
- You have any condition where formulation precision matters (severe diabetes, kidney disease).
- You're pregnant, nursing, or planning pregnancy (compounded products are not appropriate).
- Your insurance covers the brand, even with a copay above $25.
Red Flags When Buying a Cheap GLP-1
The cheap end of the GLP-1 market has both legitimate compounding pharmacies and outright scams. Cheap is fine. Cheap with no medical oversight is not.
Walk away if a provider
- Doesn't require any medical intake form or consultation.
- Won't name the compounding pharmacy supplying the medication.
- Sells "research-only" peptide vials for human use (this is the gray-market peptide world, not compounded medicine).
- Asks for crypto, Zelle, or wire transfer instead of standard credit card.
- Won't provide a Certificate of Analysis if you ask for one.
- Has no licensed prescriber listed by name and state.
Frequently Asked Questions
How to Get the Cheapest GLP-1: Step by Step
Use this sequence to land on the lowest legal price for your situation without overpaying or falling into a gray-market trap.
- Check your insurance first. Call the pharmacy benefit number on your card and ask whether GLP-1s are covered for your indication (Type 2 diabetes or obesity). If yes, a manufacturer savings card from Mounjaro, Zepbound, or NovoCare can put you at $25 per month, which beats every cash route.
- If you have no coverage, compare FDA-approved cash options. Price the LillyDirect Zepbound vial ($299 to $449 per month) and oral Wegovy tablets ($149 to $199 per month) against the brand pen retail price. These carry the FDA-approved label.
- Evaluate compounded telehealth for the lowest floor. Compounded semaglutide ($99 to $249 per month) and tirzepatide ($125 to $399 per month) are the cheapest legal routes. Only use a platform that names its 503A compounding pharmacy and assigns a licensed prescriber.
- Complete a real medical intake. A legitimate provider requires a health questionnaire, sometimes labs, and a prescriber review before shipping. Skip any seller that bypasses this step.
- Add up the true monthly cost. Include membership fees, lab work, shipping, and dose-tier price jumps before you commit. A $99 headline can become $200 once everything is added.
- Stack tax-advantaged dollars. Pay with an HSA or FSA where eligible for an effective 22% to 37% discount, and check GoodRx or SingleCare coupons for older GLP-1s like Saxenda and Victoza.
- Reassess at each titration. Most platforms raise the price at 7.5 mg and above. Confirm the maintenance-dose price before you start so the long-term cost matches the introductory offer.
The Bottom Line
If you have commercial insurance and a qualifying diagnosis, the savings card route gets you to $25 a month and almost nothing beats it. If you don't, compounded semaglutide at $99 to $249 a month is the lowest legal floor, and the LillyDirect Zepbound vial at $299 is the cheapest FDA-approved cash option. Brand-name retail at $1,000+ is the worst value in the market in 2026 and almost nobody should be paying it.
Related: Cheapest Tirzepatide · GLP-1 Without Insurance: Cash-Pay Programs · Ozempic, Wegovy & Zepbound Without Insurance · Get a GLP-1 Prescription Online · Best Online GLP-1 Program
References
- U.S. Food and Drug Administration: FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - Regulatory context for compounded and non-FDA-approved GLP-1 products.
- NovoCare: Wegovy Savings Offer - Novo Nordisk savings card and cash-pay terms for brand Wegovy.
- NovoCare - Novo Nordisk patient access programs for Ozempic, Wegovy, and Rybelsus.
- FDA Drugs@FDA: Tirzepatide (Zepbound) Approval Record - Confirms FDA-approved status of tirzepatide for chronic weight management.
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med (SURMOUNT-1), PubMed - Pivotal efficacy data for tirzepatide.
- Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity, PMC - Real-world semaglutide weight-loss evidence.
- Cleveland Clinic: GLP-1 Agonists - Clinical overview of how GLP-1 medications work and their side effects.
- CMS: Medicare Prescription Drug Coverage - Medicare Part D coverage rules underlying the weight-loss exclusion.